Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Cynthia Campbell and Bobbi Yarborough.
Connection Strength

2.363
  1. Patient and System Characteristics Associated with Performance on the HEDIS Measures of Alcohol and Other Drug Treatment Initiation and Engagement. J Addict Med. 2018 Jul/Aug; 12(4):278-286.
    View in: PubMed
    Score: 0.654
  2. Association of initial opioid prescription duration and an opioid refill by pain diagnosis: Evidence from outpatient settings in ten US health systems. Prev Med. 2024 Feb; 179:107828.
    View in: PubMed
    Score: 0.239
  3. The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment. Addiction. 2022 Jul 11.
    View in: PubMed
    Score: 0.216
  4. Development and implementation of a prescription opioid registry across diverse health systems. JAMIA Open. 2022 Jul; 5(2):ooac030.
    View in: PubMed
    Score: 0.214
  5. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021 01 31; 16(1):9.
    View in: PubMed
    Score: 0.196
  6. Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings. Subst Abus. 2019 Jan 31; 1-7.
    View in: PubMed
    Score: 0.170
  7. Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems. Subst Abus. 2019 Jan 24; 1-7.
    View in: PubMed
    Score: 0.170
  8. Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder. Psychiatr Serv. 2022 Jun 16; appips202100665.
    View in: PubMed
    Score: 0.054
  9. Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems. Addict Sci Clin Pract. 2021 07 07; 16(1):46.
    View in: PubMed
    Score: 0.050
  10. Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV. J Gen Intern Med. 2021 04; 36(4):930-937.
    View in: PubMed
    Score: 0.049
  11. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems. J Subst Abuse Treat. 2020 03; 112S:41-48.
    View in: PubMed
    Score: 0.046
  12. Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness. BMC Psychiatry. 2020 01 31; 20(1):40.
    View in: PubMed
    Score: 0.046
  13. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020 02 01; 207:107732.
    View in: PubMed
    Score: 0.045
  14. Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis. Subst Abus. 2019 Mar 25; 1-9.
    View in: PubMed
    Score: 0.043
  15. Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems. Subst Abus. 2019 Jan 25; 1-7.
    View in: PubMed
    Score: 0.043
  16. The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders. Subst Abus. 2019 Jan 24; 1-10.
    View in: PubMed
    Score: 0.043
  17. Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015. Subst Abus. 2019 Jan 24; 1-11.
    View in: PubMed
    Score: 0.043
  18. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7?US health systems. Subst Abus. 2019 Jan 18; 1-10.
    View in: PubMed
    Score: 0.042

© 2024 Kaiser Permanente